Han H - Search Results

1

Effect of acoustic cluster therapy (ACT®) combined with chemotherapy in a patient-derived xenograft mouse model of pancreatic cancer.

Ng S, Healey AJ, Sontum PC, Kvåle S, Torp SH, Sulheim E, Von Hoff D, Han H. Ng S, et al. Among authors: han h. J Control Release. 2022 Dec;352:1134-1143. doi: 10.1016/j.jconrel.2022.11.016. Epub 2022 Nov 21. J Control Release. 2022. PMID: 36372388 Free article.

2

Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray.

Han H, Bearss DJ, Browne LW, Calaluce R, Nagle RB, Von Hoff DD. Han H, et al. Cancer Res. 2002 May 15;62(10):2890-6. Cancer Res. 2002. PMID: 12019169

3

The mitotic serine threonine kinase, Aurora-2, is a potential target for drug development in human pancreatic cancer.

Rojanala S, Han H, Muñoz RM, Browne W, Nagle R, Von Hoff DD, Bearss DJ. Rojanala S, et al. Among authors: han h. Mol Cancer Ther. 2004 Apr;3(4):451-7. Mol Cancer Ther. 2004. PMID: 15078988

4

PRL phosphatases as potential molecular targets in cancer.

Stephens BJ, Han H, Gokhale V, Von Hoff DD. Stephens BJ, et al. Among authors: han h. Mol Cancer Ther. 2005 Nov;4(11):1653-61. doi: 10.1158/1535-7163.MCT-05-0248. Mol Cancer Ther. 2005. PMID: 16275986 Review.

5

Targeting loss-of-function mutations in tumor-suppressor genes as a strategy for development of cancer therapeutic agents.

Wang H, Han H, Mousses S, Von Hoff DD. Wang H, et al. Among authors: han h. Semin Oncol. 2006 Aug;33(4):513-20. doi: 10.1053/j.seminoncol.2006.04.013. Semin Oncol. 2006. PMID: 16890805 Review.

6

Aurora sheds light on head and neck squamous cell carcinoma.

Han H, Von Hoff DD. Han H, et al. Clin Cancer Res. 2006 Sep 1;12(17):5003-4. doi: 10.1158/1078-0432.CCR-06-1329. Clin Cancer Res. 2006. PMID: 16951211 Review. No abstract available.

7

Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cells.

Wang H, Han H, Von Hoff DD. Wang H, et al. Among authors: han h. Cancer Res. 2006 Oct 1;66(19):9722-30. doi: 10.1158/0008-5472.CAN-05-4602. Cancer Res. 2006. PMID: 17018631

8

Comparing Aurora A and Aurora B as molecular targets for growth inhibition of pancreatic cancer cells.

Warner SL, Munoz RM, Stafford P, Koller E, Hurley LH, Von Hoff DD, Han H. Warner SL, et al. Among authors: han h. Mol Cancer Ther. 2006 Oct;5(10):2450-8. doi: 10.1158/1535-7163.MCT-06-0202. Mol Cancer Ther. 2006. PMID: 17041088

9

Identification of a novel inhibitor of urokinase-type plasminogen activator.

Zhu M, Gokhale VM, Szabo L, Munoz RM, Baek H, Bashyam S, Hurley LH, Von Hoff DD, Han H. Zhu M, et al. Among authors: han h. Mol Cancer Ther. 2007 Apr;6(4):1348-56. doi: 10.1158/1535-7163.MCT-06-0520. Mol Cancer Ther. 2007. PMID: 17431113

10

Small interfering RNA-mediated knockdown of PRL phosphatases results in altered Akt phosphorylation and reduced clonogenicity of pancreatic cancer cells.

Stephens B, Han H, Hostetter G, Demeure MJ, Von Hoff DD. Stephens B, et al. Among authors: han h. Mol Cancer Ther. 2008 Jan;7(1):202-10. doi: 10.1158/1535-7163.MCT-07-0542. Epub 2008 Jan 9. Mol Cancer Ther. 2008. PMID: 18187808

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,026 results

Search Page

Filters